Clinical Trials Directory

Trials / Terminated

TerminatedNCT06295354

Early Variations in Immune Aging

Status
Terminated
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Accepted

Summary

Background: Despite an increase in lifespan over the last decades, our healthspan lags behind. In our aging population, it is pressing that we prevent age-related morbidities and associated burden on the health care system. Instead of investigating aging in already aged populations, the currently proposed study aims to elucidate the process of immune aging in relation to biological aging, demographic and lifestyle factors in young and midlife adults, and to identify early biomarkers and pathways associated with fast versus slow immune aging and aging endotypes. Study design: A single-center, observational prospective cohort study in the Netherlands. Participants from priorly established cohorts will be invited to join the EVIA-study. We will obtain demographic and basic clinical data and biological samples (blood and stool) at baseline and after three years, with a short, yearly online questionnaire in between.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention, we just study 'aging'No intervention, we just study 'aging'

Timeline

Start date
2024-10-07
Primary completion
2025-01-27
Completion
2025-03-18
First posted
2024-03-06
Last updated
2025-05-01

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06295354. Inclusion in this directory is not an endorsement.